eCD4-Ig promotes ADCC activity of sera from HIV-1-infected patients.
Antibody-dependent cell-mediated cytotoxity (ADCC) can eliminate HIV-1 infected cells, and may help reduce the reservoir of latent virus in infected patients. Sera of HIV-1 positive individuals include a number of antibodies that recognize epitopes usually occluded on HIV-1 envelope glycoprotein (En...
Main Authors: | Meredith E Davis-Gardner, Matthew R Gardner, Barnett Alfant, Michael Farzan |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-12-01
|
Series: | PLoS Pathogens |
Online Access: | http://europepmc.org/articles/PMC5749896?pdf=render |
Similar Items
-
OP 6.8 – 00102 In vivo evolution of env in SHIV-AD8-infected rhesus macaques after AAV-eCD4-Ig therapy
by: D. O'Hagan, et al.
Published: (2022-12-01) -
A lentiviral vector B cell gene therapy platform for the delivery of the anti-HIV-1 eCD4-Ig-knob-in-hole-reversed immunoadhesin
by: Eirini Vamva, et al.
Published: (2023-03-01) -
The Potential of eCD4-Ig, Delivered by Adeno-Associated Virus (AAV) Vector as a Novel Vaccine for HIV/AIDS Infection
by: Ghea Mangkuliguna
Published: (2021-02-01) -
Piperidine CD4-Mimetic Compounds Expose Vulnerable Env Epitopes Sensitizing HIV-1-Infected Cells to ADCC
by: Shilei Ding, et al.
Published: (2023-05-01) -
Diverse pathways of escape from all well-characterized VRC01-class broadly neutralizing HIV-1 antibodies.
by: Yuka Otsuka, et al.
Published: (2018-08-01)